Calling dip buyers! I reckon this FTSE 100 dividend stock is a brilliant buy following October’s sell-off

I think it’s a great time to go shopping for FTSE 100 (INDEXFTSE: UKX) income shares and for this blue-chip beauty in particular.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

October has proved to be a month to forget for Reckitt Benckiser Group (LSE: RB). The household goods manufacturer hit the ground running by posting one-year highs above £71 per share, but soon succumbed to the washout we witnessed across all share markets. In total it has lost 10% of its value this month, a disappointing set of financials released in that time having compounded investor bearishness.

The Nurofen and Durex maker declared just yesterday that manufacturing difficulties at its baby milk factory in Europe meant that it was unable to meet strong demand. As a consequence, revenues for the third quarter took a hit to the tune of around £70m.

What’s more, although the disruption has now been resolved, Reckitt warned that it expects some residual impact through the remainder of the year and into 2019. This is the worst possible start the business could have had after snapping up US formula giant Mead Johnson back in 2017.

Developing markets still performing

Disappointing news, no doubt. But aside from these woes, the FTSE 100 firm’s latest release provided plenty for glass-half-full investors to get their teeth into.

Time and again I’ve celebrated what the firm’s extensive developing market exposure should mean for future profits growth. And I’m pleased to see that in this regard its Q3 numbers didn’t let me down.

Okay, like-for-like sales of its Health products may have dipped 1% between July and September, but this reverse can be explained away by those production problems I mentioned earlier. Indeed, the brilliant sales potential of its products in these future economic powerhouses was underlined by a 12% like-for-like sales improvement at the company’s Hygiene Home arm.

Of course the company isn’t immune to a little earnings turbulence from time to time but, over the long term, investors can expect the Footsie firm to deliver decent profits growth thanks to the strength of its product catalogue, its dedication to innovation, and its broad geographic footprint.

In fact, these qualities mean that Reckitt  is still expected to record a 2% earnings rise in 2018, despite those problems at its Dutch milk powder facility. And City brokers believe it will follow this year’s anticipated rise with a further 8% improvement in 2019 too.

Dividend dynamo

The recent share sale I spoke about earlier means that the firm can be picked up on a forward P/E ratio of 19.3 times. This isn’t exactly cheap from a conventional perspective, the reading sitting outside the widely-regarded value terrain of 15 times and below. But compared to its traditional, elevated, valuations the company can be considered a snip at the current time.

Besides, its status as a reliable profits grower means that it remains a good pick for those seeking dividend rises as well. A 168.5p per share reward is forecast for this year, up from 164.3p last year, and a 180.9p payout is forecast for 2019.

These forecasts yield a chubby 2.7% and 2.9% respectively, and are covered 2 times by anticipated earnings, bang on the accepted security benchmark. While bigger yields can be found on the FTSE 100, I think Reckitt Benckiser is in much better shape than most to continue raising the dividend year after year. It’s a white-hot buy right now, I believe.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »